Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation.
In order to identify the individual contributions of the kringle (K) domains of human plasminogen (Pg) to the epsilon-aminocaproic acid (EACA) induced stimulation of Pg activation by low-molecular-weight urokinase-type plasminogen activator (LMW-uPA) and inhibition of this same activation by Cl-, we constructed the most conservative recombinant- (r-) Pg mutants possible that would greatly reduce the strength of the EACA binding site in the omega-amino acid binding kringles, [K1Pg] ([D139-->N]r-Pg), [K4Pg] ([D413-->N]r-Pg), and [K5Pg] ([D515--N]r-Pg). In each case, this involved mutation of a critical Asp (to Asn) within these three kringle domains in intact Pg. The three r-mutants were expressed in r-baculovirus-infected lepidopteran insect (Trichoplusia ni) cells. In the presence of Cl-, the positive activation effector, EACA, first stimulated and then inhibited the LMW-uPA-catalyzed initial activation of wild-type (wt) r-[Glu1]Pg and, to a lesser extent, the [K5Pg] mutant, [D518-->N/Glu1]r-Pg. The concentration of EACA that produced 50% stimulation of activation (C50) occurred at 3.3 mM for wtr-[Glu1]Pg and at 0.7 mM for [D518-->N/Glu1]r-Pg. Subsequent inhibition by EACA occurred with a C50 of approximately 15 mM and is likely due to inhibition of the amidolytic activity of plasmin generated during the activation. Similar initial activation rates of both [D139-->N]r-Pg and [D413N]r-Pg did not display this initial EACA-mediated stimulatory phase but did undergo ultimate inhibition with a C50 for this process that was similar to wtr-[Glu1]Pg and [D518-->N/Glu1]r-Pg.(ABSTRACT TRUNCATED AT 250 WORDS)
Department of Chemistry and Biochemistry, University of Notre Dame, Indiana 46556.
N
N
Menhart
G J
GJ
Hoover
S G
SG
McCance
F J
FJ
Castellino
D000614:Aminocaproates / Q000494:pharmacology*; D001483:Base Sequence; D001665:Binding Sites; D002712:Chlorides / Q000494:pharmacology*; D018076:DNA, Complementary; D006801:Humans; D018082:Kringles; D008969:Molecular Sequence Data; D009154:Mutation; D010958:Plasminogen / Q000819:agonists / Q000037:antagonists & inhibitors / Q000737:chemistry* / Q000235:genetics; D010960:Plasminogen Activators / Q000494:pharmacology*; D011487:Protein Conformation
D000614:Aminocaproates; D002712:Chlorides; D018076:DNA, Complementary; D010958:Plasminogen; D010960:Plasminogen Activators